Table 2.
Serum levels of CK-MB, cTnI, h-FABP, NO, and vWF in the control groups, expressed as x̅ ± s.
| CK-MB (U/L) | cTnI (ng/mL) | h-FABP (ng/mL) | NO (μmol/L) | vWF (ng/ml) | |
|---|---|---|---|---|---|
| Pre-PCI | 11.25 ± 3.74 | 0.05 ± 0.18 | 0.84 ± 0.98 | 78.50 ± 3.75 | 2.18 ± 1.14 |
| Post-PCI | 16.02 ± 11.01 | 0.47 ± 0.19 | 0.90 ± 1.04 | 54.31 ± 4.97 | 2.62 ± 1.30 |
| P values | 0.043∗ | 0.000∗ | 0.333 | 0.000∗ | 0.005∗ |
PCI: percutaneous coronary intervention, CK-MB: creatine kinase-muscle/brain, cTnI: cardiac troponin I, h-FABP: heart-type fatty acid-binding protein, vWF: von Willebrand factor, and NO: nitric oxide.